©The Author(s) 2025.
World J Gastroenterol. Sep 7, 2025; 31(33): 107408
Published online Sep 7, 2025. doi: 10.3748/wjg.v31.i33.107408
Published online Sep 7, 2025. doi: 10.3748/wjg.v31.i33.107408
Table 3 Univariate analysis of parameters in patients with compensated and decompensated cirrhosis
| Parameter | Patients with compensatory stage of cirrhosis, n = 72 | Patients with decompensation of cirrhosis, n = 68 | t/Z | P value |
| SSM, kPa | 23.50 ± 6.1 | 18.32 ± 4.2 | 5.866 | < 0.001 |
| PLT, × 109/L | 110.51 ± 69.1 | 61.81 ± 25.7 | 5.463 | < 0.001 |
| LSM, kPa | 15.53 ± 5.7 | 23.86 ± 5.2 | -9.023 | < 0.001 |
| ALT, IU/L | 36.00 (24.00, 47.75) | 27.50 (17.00, 42.25) | -2.490 | 0.013 |
| AST, IU/L | 40.50 (26.75, 58.75) | 38.00 (29.00, 56.75) | -0.452 | 0.651 |
| ALP, IU/L | 105.00 (77.50, 143.00) | 98.50 (79.25, 135.50) | -0.709 | 0.478 |
| GGT, IU/L | 61.00 (28.00, 120.00) | 34.50 (19.25, 59.50) | -3.718 | < 0.001 |
| SLD, mm | 12.99 ± 3.0 | 15.68 ± 3.1 | -5.282 | < 0.001 |
| TBIL, μmol/L | 29.64 ± 27.0 | 31.27 ± 16.2 | -0.430 | 0.668 |
| ALB, g/dL | 38.69 ± 6.4 | 34.43 ± 7.4 | 3.691 | < 0.001 |
| TCHO, mmol/L | 3.67 ± 1.3 | 3.09 ± 0.9 | 2.939 | 0.004 |
| PT, seconds | 12.08 ± 1.9 | 13.70 ± 2.5 | -4.322 | < 0.001 |
| INR | 1.10 ± 0.2 | 1.24 ± 0.2 | -4.029 | < 0.001 |
| PTA,% | 84.91 ± 18.9 | 72.37 ± 17.0 | 4.123 | < 0.001 |
| PVD, mm | 12.03 ± 1.6 | 13.78 ± 2.4 | -5.072 | < 0.001 |
| CTLV, cm3 | 1055.93 ± 344.8 | 898.64 ± 257.3 | 3.045 | 0.003 |
| CTSV, cm3 | 519.10 ± 296.0 | 842.19 ± 416.3 | -5.315 | < 0.001 |
- Citation: Yang LB, Gao X, Xu M, Li Y, Dong L, Huang XD, She X, Zhang DY, Zhang QW, Liu CY, Fan ST, Wang Y. Noninvasive model based on liver and spleen stiffness for predicting clinical decompensation in patients with cirrhosis. World J Gastroenterol 2025; 31(33): 107408
- URL: https://www.wjgnet.com/1007-9327/full/v31/i33/107408.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i33.107408